Transgenic mice expressing the βAPP695SWE mutation: Effects on exploratory activity, anxiety, and motor coordination

Brain Research

Volumn 977, Issue 1, 2003, Pages 38-45

  Lalonde, R ^a,e   Lewis, T L ^b   Strazielle, C ^c   Kim, H ^d   Fukuchi, K ^b  

^a UNIVERSITÉ DE ROUEN   (France)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITÉ DE LORRAINE   (France)

^d The Purdue Univ Univ of Alabama at Birmingham Botanical Center for Age Related Disease   (United States)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Amyloid precursor protein; Anxiety; Apathy; A protein; Disinhibition; Familial Alzheimer's disease; Motor activity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; GENE MUTATION; HIPPOCAMPUS; INHIBITION (PSYCHOLOGY); MALE; MAZE TEST; MOTOR COORDINATION; MOUSE; NEOCORTEX; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENE; TRANSGENIC MOUSE; VACCINATION;

EID: 0038022595     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02694-5     Document Type: Article

References (37)

1. Arendash G.W., King D.L. Intra- and intertask relationships in a behavioral test battery given to Tg2576 transgenic mice and controls. Physiol. Behav. 75:2002;643-652.
2. Arendash G.W., Gordon M.N., Diamond D.M., Austin L.A., Hatcher J.M., DiCarlo G., et al. Behavioral assessment of Alzheimer's transgenic mice following long-term Aβ vaccination: task specificity and correlations between Aβ and spatial memory. DNA Cell Biol. 20:2001;737-744.
3. Arendash G.W., King D.L., Gordon M.N., Morgan D., Hatcher J.M., Hope C.E., et al. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891:2001;42-53.
4. Campion D., Brice A., Dumanchin C., Puel M., Baulac M., De la Sayette V., et al. A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. NeuroReport. 7:1996;1582-1584.
5. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2:1999;271-276.
6. Chung J.A., Cummings J.L. Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease. Neurol. Clin. 18:2000;829-846.
7. Daffner K.R., Scinto L.F.M., Weintraub S., Guinessey J.E., Mesulam M.M. Diminished curiosity in patients with probable Alzheimer's disease as measured by exploratory eye movements. Neurology. 42:1992;320-328.
8. Dember W.N., Fowler H. Spontaneous alternation after free and forced trials. Can. J. Psychol. 13:1959;151-154.
9. Förstl H., Burns A., Levy R., Cairns N., Luthert P., Lantos P. Neurologic signs in Alzheimer's disease: results of a prospective clinical and neuropathologic study. Arch. Neurol. 49:1992;1038-1042.
10. Frisoni G.B., Rozzini L., Gozetti A., Binetti G., Zanetti O., Bianchetti A., et al. Behavioral syndromes in Alzheimer's disease: description and correlates. Dement. Geriatr. Cogn. Disord. 10:1999;130-138.
11. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin transgenes. Nat. Med. 4:1998;97-100.
12. Holcomb L.A., Gordon M.N., Jantzen P., Hsaio K., Duff K., Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Genet. 29:1999;177-185.
13. Holmes A., Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci. Biobehav. Rev. 23:1999;971-980.
14. Hsiao K.K., Borchelt D.R., Olson K., Johannsdottir R., Kitt C., Yunis W., et al. Age-related CNS disorder and early death in transgenic FVB-N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1203-1208.
15. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
16. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron. 13:1994;45-53.
17. J Eslinger P., Damasio A.R. Preserved motor learning in Alzheimer's disease: implications for anatomy and behavior. J. Neurosci. 6:1986;3006-3009.
18. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21:2001;372-381.
19. King D.L., Arendash G.W. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol. Behav. 75:2002;627-642.
20. King D.L., Arendash G.W., Crawford F., Sterk T., Menendez J., Mullan M.J. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav. Brain Res. 103:1999;145-162.
21. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 26:2002;91-104.
22. Lalonde R., Dumont M., Sturchler-Pierrat C., Staufenbiel M., Strazielle C. Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res. 956:2002;36-44.
23. Lalonde R., Dumont M., Fukuchi K., Strazielle C. Transgenic mice expressing the human C99 terminal fragment of βAPP: effects on spatial learning, exploration, anxiety, and motor coordination. Exp. Gerontol. 177:2002;521-530.
24. Lalonde R., Qian S., Strazielle C. Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination. Behav. Brain Res. 138:2003;71-79.
25. Lalonde R., Strazielle C. Motor performance of spontaneous murine mutations with cerebellar atrophy. Crusio W., Gerlai R. Handbook of Molecular-Genetic Techniques for Brain and Behavior Research, Techniques in the Behavioral and Neural Sciences. Vol. 13:1999;627-637 Elsevier, Amsterdam.
26. Moran P.M., Higgins L.S., Cordell B., C Moser P. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid protein precursor protein. Proc. Natl. Acad. Sci. USA. 92:1995;5341-5345.
27. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1:1992;345-347.
28. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
29. Petry S., Cummings J.L., Hill M.A., Shapira J. Personality alterations in dementia of the Alzheimer type. Arch. Neurol. 45:1988;1187-1190.
30. Pettersson A.F., Engardt M., Wahlund L.-O. Activity and balance in subjects with mild Alzheimer's disease. Dement. Geriatr. Cogn. Dis. 13:2002;213-216.
31. Puoliväli J., Wang J., Heikkinen T., Heikkilä M., Tapiola T., van Groen T., et al. Hippocampal Aβ42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol. Dis. 9:2002;339-347.
32. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:1999;A23-A31.
33. Swearer J.M., O'Donnell B.F., Drachman D.A., Woodward B.M. Neuropsychological features of familial Alzheimer's disease. Ann. Neurol. 32:1992;687-694.
34. Tanzi R.E., Bertram L. New frontiers in Alzheimer's disease genetics. Neuron. 32:2001;181-184.
35. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., et al. The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22:2002;1858-1867.
36. Wisniewski H.M., Wiegel J. Alzheimer's disease neuropathology: current status of interpretation of lesion development. Ann. NY Acad. Sci. 673:1992;270-284.
37. van Leuven F. Single and multiple transgenic mice as models for Alzheimer's disease. Prog. Neurobiol. 61:2000;305-312.